Dearlove v. Genzyme Transgenics Corp.

58 Pa. D. & C.4th 517, 2002 Pa. Dist. & Cnty. Dec. LEXIS 194
CourtPennsylvania Court of Common Pleas, Philadelphia County
DecidedJuly 19, 2002
Docketno. 1031
StatusPublished

This text of 58 Pa. D. & C.4th 517 (Dearlove v. Genzyme Transgenics Corp.) is published on Counsel Stack Legal Research, covering Pennsylvania Court of Common Pleas, Philadelphia County primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Dearlove v. Genzyme Transgenics Corp., 58 Pa. D. & C.4th 517, 2002 Pa. Dist. & Cnty. Dec. LEXIS 194 (Pa. Super. Ct. 2002).

Opinion

SHEPPARD JR., J.,

Defendant, Genzyme Transgenics Corporation, has filed a petition to dismiss plaintiffs’ class action complaint pursuant to 42 Pa.C.S. §5322(e). For the reasons set forth, the court is issuing a contemporaneous order denying the petition.

[519]*519FACTUAL ALLEGATIONS

Plaintiffs, George Dearlove and Annaregina Roberts, filed this class action alleging that GTC canceled the putative plaintiffs’ stock options, originally granted to them pursuant to GTC’s 1993 equity incentive plan, in violation of the plan. Compl., ¶¶29-31.

GTC is a biopharmaceuticals company with its headquarters and principal place of business at 175 Crossing Boulevard, Framingham, Massachusetts. Petition, ¶¶1-2. Framingham, Massachusetts is located approximately 290 miles from Philadelphia, Pennsylvania. Petition, ¶4; answer,1 ¶4.

Previously, GTC owned a subsidiary called Primedica Corporation, also a biotechnology company with its headquarters and principal place of business in Worcester, Massachusetts. Petition, ¶28; answer, ¶28. GTC also previously owned Primedica’s five subsidiaries: Primedica Worcester Inc. (principal place of business in Worcester, Massachusetts), Primedica Cambridge Inc. (principal place of business in Cambridge, Massachusetts), Primedica Argus Research Laboratories Inc. (principal place of business in Pennsylvania2), Primedica Redfield Inc. (principal place of business in Redfield, Arkansas), [520]*520and Primedica Rockville Inc. (principal place of business in Rockville, Maryland). Petition, ¶¶29-34; answer, ¶¶29-34. (Primedica Corporation and its five subsidiaries will be referred to in this opinion, collectively, as “Primedica.”)

The plaintiffs are employees of Primedica Argus Research Laboratories. Compl., ¶4. Plaintiff, George Dearlove, resides in Landenberg, Pennsylvania, and plaintiff, Annaregina Roberts, resides in Philadelphia, Pennsylvania. Compl., ¶¶1-2; answer, ¶51.

In 1993, GTC instituted a stock option plan entitled the 1993 equity incentive plan to award GTC stock options to the employees of GTC and Primedica. Petition, ¶¶5-6. Beginning in 1993, GTC awarded stock options pursuant to the plan to Primedica employees, including the plaintiffs. Petition, ¶¶42-43; answer, ¶¶42-43; Compl., ¶¶6, 9. The plan states that its provisions “shall be governed by and interpreted in accordance with the laws of the Commonwealth of Massachusetts.” Petition, ¶9.

On February 26,2001, GTC sold Primedica to Charles River Laboratories International Inc., a biotechnology company with its headquarters and principal place of business in Wilmington, Massachusetts. Petition, ¶¶35-36. Defendant contends that upon the sale of Primedica, “the plan required the exercise or cancellation of the vested shares held by those employees within 90 days of the closing of the sale.” Petition, ¶45. According to GTC, on March 9,2001, it notified Primedica employees who held stock options that they had until May 26, 2001 to exercise their vested options. Petition, [521]*521¶46; answer, ¶¶46, 51. Plaintiffs dispute this, contending that no Pennsylvania employee was given notice. Those stock options held by Primedica employees which were not exercised by May 26, 2001, were canceled. Compl., ¶31.

Dearlove and Roberts bring the complaint on behalf of a putative class which includes “all employees of Primedica Corporation and it[s] subsidiaries who, as of February 7, 2001, had been awarded stock options and who had not yet exercised their options.” Compl., ¶13. Plaintiffs allege that the putative class is composed of 641 former employees of Primedica. Answer, ¶¶42-43. Plaintiffs base this allegation on a document produced by defendant containing the last known addresses of all employees of Primedica who, as of February 7, 2001, had been awarded stock options and who had not yet exercised their options. Answer, exhibit 5, defendant’s response to plaintiffs’ request for interrogatories no. 1.

Plaintiffs allege that of these 641 former Primedica employees, 299 (or 46.6 percent) have addresses in Massachusetts, 145 (or 22.6 percent) have addresses in Pennsylvania (17 of whom are in Philadelphia), 70 (or 10.9 percent) have addresses in Maryland, 68 (or 10.6 percent) have addresses in Arkansas, ánd 59 (or 9 percent) have addresses in 11 other states (including 19 in Connecticut, eight in Rhode Island and six in New Hampshire). Answer, ¶42.

Defendant alleges that “[a]s of February 26, 2001, stock options issued pursuant to the plan were held by 38 current and former employees of Primedica Corporation, 301 current and former employees of Primedica [522]*522Worcester [Inc.] and Primedica Cambridge [Inc.], 78 current and former employees of Primedica Rockville [Inc.], 153 current and former employees of Primedica Argus [Research Laboratories Inc.], and 66 current and former employees of Primedica Redfield [Inc.].” Petition, ¶42.

In their complaint, plaintiffs have alleged three counts against defendant GTC: breach of contract, breach of covenant of good faith and fair dealing, and unjust enrichment. Compl., ¶¶28-36; 37-42; 43-47.

The instant petition seeks to dismiss based on forum non conveniens. Defendant contends that this case should be dismissed and brought by plaintiffs in Worcester County, Massachusetts.

DISCUSSION

I. Standard of Proof To Dismiss Based on Forum Non Conveniens

Defendant relies on 42 Pa.C.S. §5322(e), which permits a Pennsylvania court to dismiss a matter in whole or in part when the court finds that in the “interest of substantial justice” the matter should be heard in a forum outside Pennsylvania. To analyze defendant’s petition, this court also looks to Pa.R.C.P. 1006 which governs changes of venue within Pennsylvania. Both section 5322(e) and Rule 1006 are applied in the same way in cases involving a petition to transfer venue based on the common-law doctrine of forum non conveniens. Jones v. Borden Inc., 455 Pa. Super. 110, 114, 687 A.2d 392, [523]*523394 (1996), citing Shears v. Rigley, 424 Pa. Super. 559, 564, 623 A.2d 821, 824 (1993).3

To dismiss pursuant to section 5322(e), a court must first find that the case could be brought in an alternative forum. Farley v. McDonnell Douglas Truck Services Inc., 432 Pa. Super. 456, 462, 638 A.2d 1027, 1030 (1994). Once the viability of an alternative forum has been determined, the defendant has the burden of showing that the plaintiff’s choice of forum is vexatious or oppressive. The Pennsylvania Supreme Court has expounded on this “vexatious or oppressive” standard, stating:

“[T]he defendant may meet its burden of showing that the plaintiff’s choice of forum is vexatious to him by establishing with facts on the record that the plaintiff’s choice of forum was designed to harass the defendant, even at some inconvenience to the plaintiff himself....

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Phillips Petroleum Co. v. Shutts
472 U.S. 797 (Supreme Court, 1985)
Cheeseman v. Lethal Exterminator, Inc.
701 A.2d 156 (Supreme Court of Pennsylvania, 1997)
Farley v. McDonnell Douglas Truck Services, Inc.
638 A.2d 1027 (Superior Court of Pennsylvania, 1994)
Commonwealth v. McGriff
638 A.2d 1032 (Superior Court of Pennsylvania, 1994)
Hoose v. Jefferson Home Health Care, Inc.
754 A.2d 1 (Superior Court of Pennsylvania, 2000)
Shears v. Rigley
623 A.2d 821 (Superior Court of Pennsylvania, 1993)
Johnson v. Henkels & McCoy, Inc.
707 A.2d 237 (Superior Court of Pennsylvania, 1997)
GOODMAN BY GOODMAN v. Pizzutillo
682 A.2d 363 (Superior Court of Pennsylvania, 1996)
Petty v. Suburban General Hospital
525 A.2d 1230 (Supreme Court of Pennsylvania, 1987)
Jones v. BORDEN, INC., IND.
687 A.2d 392 (Superior Court of Pennsylvania, 1996)
Page v. Ekbladh
590 A.2d 1278 (Superior Court of Pennsylvania, 1991)
Nile v. Nile
432 Mass. 390 (Massachusetts Supreme Judicial Court, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
58 Pa. D. & C.4th 517, 2002 Pa. Dist. & Cnty. Dec. LEXIS 194, Counsel Stack Legal Research, https://law.counselstack.com/opinion/dearlove-v-genzyme-transgenics-corp-pactcomplphilad-2002.